[18 F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients
Purpose Our hypothesis was that pretreatment inflammation in the lung makes pulmonary tissue more susceptible to radiation damage. The relationship between pretreatment [18 F]fluorodeoxyglucose ([18 F]FDG) uptake in the lungs (as a surrogate for inflammation) and the delivered radiation dose and rad...
Gespeichert in:
Veröffentlicht in: | International journal of radiation oncology, biology, physics biology, physics, 2011-11, Vol.81 (3), p.698-705 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 705 |
---|---|
container_issue | 3 |
container_start_page | 698 |
container_title | International journal of radiation oncology, biology, physics |
container_volume | 81 |
creator | Petit, Steven F., M.Sc van Elmpt, Wouter J.C., Ph.D Oberije, Cary J.G., M.Sc Vegt, Erik, M.D Dingemans, Anne-Marie C., Ph.D Lambin, Philippe, M.D., Ph.D Dekker, André L.A.J., Ph.D De Ruysscher, Dirk, M.D., Ph.D |
description | Purpose Our hypothesis was that pretreatment inflammation in the lung makes pulmonary tissue more susceptible to radiation damage. The relationship between pretreatment [18 F]fluorodeoxyglucose ([18 F]FDG) uptake in the lungs (as a surrogate for inflammation) and the delivered radiation dose and radiation-induced lung toxicity (RILT) was investigated. Methods and Materials We retrospectively studied a prospectively obtained cohort of 101 non-small-cell lung cancer patients treated with (chemo)radiation therapy (RT). [18 F]FDG-positron emission tomography-computed tomography (PET-CT) scans used for treatment planning were studied. Different parameters were used to describe [18 F]FDG uptake patterns in the lungs, excluding clinical target volumes, and the interaction with radiation dose. An increase in the dyspnea grade of 1 (Common Terminology Criteria for Adverse Events version 3.0) or more points compared to the pre-RT score was used as an endpoint for analysis of RILT. The effect of [18 F]FDG and CT-based variables, dose, and other patient or treatment characteristics that effected RILT was studied using logistic regression. Results Increased lung density and pretreatment [18 F]FDG uptake were related to RILT after RT with univariable logistic regression. The 95th percentile of the [18 F]FDG uptake in the lungs remained significant in multivariable logistic regression ( p = 0.016; odds ratio [OR] = 4.3), together with age ( p = 0.029; OR = 1.06), and a pre-RT dyspnea score of ≥1 ( p = 0.005; OR = 0.20). Significant interaction effects were demonstrated among the 80th, 90th, and 95th percentiles and the relative lung volume receiving more than 2 and 5 Gy. Conclusions The risk of RILT increased with the 95th percentile of the [18 F]FDG uptake in the lungs, excluding clinical tumor volume (OR = 4.3). The effect became more pronounced as the fraction of the 5%, 10%, and 20% highest standardized uptake value voxels that received more than 2 Gy to 5 Gy increased. Therefore, the risk of RILT may be decreased by applying sophisticated radiotherapy techniques to avoid areas in the lung with high [18 F]FDG uptake. |
doi_str_mv | 10.1016/j.ijrobp.2010.06.016 |
format | Article |
fullrecord | <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_21590429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0360301610008655</els_id><sourcerecordid>1257888487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c553t-b4d1b8cdef95af4bcce16c7e2dfcb18303565c6123c0f43d854798e8f4eaaffc3</originalsourceid><addsrcrecordid>eNqFktuKFDEQhhtR3HH1DUQaRPCmx6SP6RthHVwdGA84uyCIhHRS2U1vJmmTtGy_lM9o2h4VvPEqUPmq6q_6K0keY7TGCNcv-rXqne2GdY5iCNXrGLyTrDBp2qyoqs93kxUqapQVMX6SPPC-Rwhh3JT3k5McEVLinKySH18wSc-_Sj1aZwXY2-lKj9x6SC-HwG4g_chCAGd8qky6G81V-gqkdZB-YkLZcA2ODVO6FWCCklN65oD59N0M7EfPYQiq05AG-4tnQVmTbY0YOYil2oW9VVyFaS7_Pn7uD0zrbANaL_8bZji4WYWKLfzD5J5k2sOj43uaXJ6_vti8zXYf3mw3Z7uMV1URsq4UuCNcgGwrJsuOc8A1byAXkneYFKio6orXOC84kmUhSFU2LQEiS2BMSl6cJk-XutYHRX1UCPyaW2OAB5rjqkVl3kbq-UINzn4bwQd6UHForZkBO3qK86ohcdOkiWi5oNxZ7x1IOjh1YG6iGNHZT9rTxU86-0lRTWMwpj05dhi7A4g_Sb8NjMCzI8A8Z1q6uC_l_3Jlg5qmnaW-XDiIW_uuwM1DQdytUG6eSVj1PyX_FuBaGRV73sAEvrejM9ERiqnPKaL7-fbm08Px6kgdXfkJtc3X_w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1257888487</pqid></control><display><type>article</type><title>[18 F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Petit, Steven F., M.Sc ; van Elmpt, Wouter J.C., Ph.D ; Oberije, Cary J.G., M.Sc ; Vegt, Erik, M.D ; Dingemans, Anne-Marie C., Ph.D ; Lambin, Philippe, M.D., Ph.D ; Dekker, André L.A.J., Ph.D ; De Ruysscher, Dirk, M.D., Ph.D</creator><creatorcontrib>Petit, Steven F., M.Sc ; van Elmpt, Wouter J.C., Ph.D ; Oberije, Cary J.G., M.Sc ; Vegt, Erik, M.D ; Dingemans, Anne-Marie C., Ph.D ; Lambin, Philippe, M.D., Ph.D ; Dekker, André L.A.J., Ph.D ; De Ruysscher, Dirk, M.D., Ph.D</creatorcontrib><description>Purpose Our hypothesis was that pretreatment inflammation in the lung makes pulmonary tissue more susceptible to radiation damage. The relationship between pretreatment [18 F]fluorodeoxyglucose ([18 F]FDG) uptake in the lungs (as a surrogate for inflammation) and the delivered radiation dose and radiation-induced lung toxicity (RILT) was investigated. Methods and Materials We retrospectively studied a prospectively obtained cohort of 101 non-small-cell lung cancer patients treated with (chemo)radiation therapy (RT). [18 F]FDG-positron emission tomography-computed tomography (PET-CT) scans used for treatment planning were studied. Different parameters were used to describe [18 F]FDG uptake patterns in the lungs, excluding clinical target volumes, and the interaction with radiation dose. An increase in the dyspnea grade of 1 (Common Terminology Criteria for Adverse Events version 3.0) or more points compared to the pre-RT score was used as an endpoint for analysis of RILT. The effect of [18 F]FDG and CT-based variables, dose, and other patient or treatment characteristics that effected RILT was studied using logistic regression. Results Increased lung density and pretreatment [18 F]FDG uptake were related to RILT after RT with univariable logistic regression. The 95th percentile of the [18 F]FDG uptake in the lungs remained significant in multivariable logistic regression ( p = 0.016; odds ratio [OR] = 4.3), together with age ( p = 0.029; OR = 1.06), and a pre-RT dyspnea score of ≥1 ( p = 0.005; OR = 0.20). Significant interaction effects were demonstrated among the 80th, 90th, and 95th percentiles and the relative lung volume receiving more than 2 and 5 Gy. Conclusions The risk of RILT increased with the 95th percentile of the [18 F]FDG uptake in the lungs, excluding clinical tumor volume (OR = 4.3). The effect became more pronounced as the fraction of the 5%, 10%, and 20% highest standardized uptake value voxels that received more than 2 Gy to 5 Gy increased. Therefore, the risk of RILT may be decreased by applying sophisticated radiotherapy techniques to avoid areas in the lung with high [18 F]FDG uptake.</description><identifier>ISSN: 0360-3016</identifier><identifier>EISSN: 1879-355X</identifier><identifier>DOI: 10.1016/j.ijrobp.2010.06.016</identifier><identifier>PMID: 20884128</identifier><identifier>CODEN: IOBPD3</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Age ; Age Factors ; Aged ; Aged, 80 and over ; ANTIMETABOLITES ; BETA DECAY RADIOISOTOPES ; BETA-PLUS DECAY RADIOISOTOPES ; Biological and medical sciences ; BODY ; Carcinoma, Non-Small-Cell Lung - diagnostic imaging ; Carcinoma, Non-Small-Cell Lung - metabolism ; Carcinoma, Non-Small-Cell Lung - radiotherapy ; CAT SCANNING ; Chemoradiotherapy ; COMPUTERIZED TOMOGRAPHY ; DIAGNOSTIC TECHNIQUES ; DISEASES ; DOSES ; DRUGS ; Dyspnea ; Dyspnea - etiology ; EMISSION COMPUTED TOMOGRAPHY ; Female ; FLUORINE 18 ; FLUORINE ISOTOPES ; FLUORODEOXYGLUCOSE ; Fluorodeoxyglucose (FDG) ; Fluorodeoxyglucose F18 - pharmacokinetics ; HAZARDS ; Hematology, Oncology and Palliative Medicine ; HOURS LIVING RADIOISOTOPES ; Humans ; HYPOTHESIS ; INFLAMMATION ; ISOMERIC TRANSITION ISOTOPES ; ISOTOPES ; LIGHT NUCLEI ; Logistic Models ; Lung ; Lung - diagnostic imaging ; Lung - metabolism ; Lung - radiation effects ; Lung cancer ; Lung Neoplasms - diagnostic imaging ; Lung Neoplasms - metabolism ; Lung Neoplasms - radiotherapy ; LUNGS ; Male ; Medical sciences ; MEDICINE ; Middle Aged ; Multimodal Imaging - methods ; NANOSECONDS LIVING RADIOISOTOPES ; NEOPLASMS ; NUCLEAR MEDICINE ; NUCLEI ; ODD-ODD NUCLEI ; Odds Ratio ; ORGANS ; PATHOLOGICAL CHANGES ; Pneumology ; PNEUMONITIS ; POSITRON COMPUTED TOMOGRAPHY ; Positron emission tomography (PET) ; Positron-Emission Tomography ; Radiation ; RADIATION DOSES ; RADIATION EFFECTS ; Radiation Pneumonitis - diagnostic imaging ; Radiation Pneumonitis - metabolism ; Radiation-induced lung toxicity (RILT) ; RADIOISOTOPES ; RADIOLOGY ; RADIOLOGY AND NUCLEAR MEDICINE ; Radiopharmaceuticals - pharmacokinetics ; RADIOTHERAPY ; Respiration ; RESPIRATORY SYSTEM ; Respiratory system : syndromes and miscellaneous diseases ; Retrospective Studies ; SYMPTOMS ; THERAPY ; TOMOGRAPHY ; Tomography, X-Ray Computed ; TOXICITY ; Tumors ; Tumors of the respiratory system and mediastinum</subject><ispartof>International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.698-705</ispartof><rights>Elsevier Inc.</rights><rights>2011 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c553t-b4d1b8cdef95af4bcce16c7e2dfcb18303565c6123c0f43d854798e8f4eaaffc3</citedby><cites>FETCH-LOGICAL-c553t-b4d1b8cdef95af4bcce16c7e2dfcb18303565c6123c0f43d854798e8f4eaaffc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijrobp.2010.06.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24707799$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20884128$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/21590429$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Petit, Steven F., M.Sc</creatorcontrib><creatorcontrib>van Elmpt, Wouter J.C., Ph.D</creatorcontrib><creatorcontrib>Oberije, Cary J.G., M.Sc</creatorcontrib><creatorcontrib>Vegt, Erik, M.D</creatorcontrib><creatorcontrib>Dingemans, Anne-Marie C., Ph.D</creatorcontrib><creatorcontrib>Lambin, Philippe, M.D., Ph.D</creatorcontrib><creatorcontrib>Dekker, André L.A.J., Ph.D</creatorcontrib><creatorcontrib>De Ruysscher, Dirk, M.D., Ph.D</creatorcontrib><title>[18 F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients</title><title>International journal of radiation oncology, biology, physics</title><addtitle>Int J Radiat Oncol Biol Phys</addtitle><description>Purpose Our hypothesis was that pretreatment inflammation in the lung makes pulmonary tissue more susceptible to radiation damage. The relationship between pretreatment [18 F]fluorodeoxyglucose ([18 F]FDG) uptake in the lungs (as a surrogate for inflammation) and the delivered radiation dose and radiation-induced lung toxicity (RILT) was investigated. Methods and Materials We retrospectively studied a prospectively obtained cohort of 101 non-small-cell lung cancer patients treated with (chemo)radiation therapy (RT). [18 F]FDG-positron emission tomography-computed tomography (PET-CT) scans used for treatment planning were studied. Different parameters were used to describe [18 F]FDG uptake patterns in the lungs, excluding clinical target volumes, and the interaction with radiation dose. An increase in the dyspnea grade of 1 (Common Terminology Criteria for Adverse Events version 3.0) or more points compared to the pre-RT score was used as an endpoint for analysis of RILT. The effect of [18 F]FDG and CT-based variables, dose, and other patient or treatment characteristics that effected RILT was studied using logistic regression. Results Increased lung density and pretreatment [18 F]FDG uptake were related to RILT after RT with univariable logistic regression. The 95th percentile of the [18 F]FDG uptake in the lungs remained significant in multivariable logistic regression ( p = 0.016; odds ratio [OR] = 4.3), together with age ( p = 0.029; OR = 1.06), and a pre-RT dyspnea score of ≥1 ( p = 0.005; OR = 0.20). Significant interaction effects were demonstrated among the 80th, 90th, and 95th percentiles and the relative lung volume receiving more than 2 and 5 Gy. Conclusions The risk of RILT increased with the 95th percentile of the [18 F]FDG uptake in the lungs, excluding clinical tumor volume (OR = 4.3). The effect became more pronounced as the fraction of the 5%, 10%, and 20% highest standardized uptake value voxels that received more than 2 Gy to 5 Gy increased. Therefore, the risk of RILT may be decreased by applying sophisticated radiotherapy techniques to avoid areas in the lung with high [18 F]FDG uptake.</description><subject>Adult</subject><subject>Age</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>ANTIMETABOLITES</subject><subject>BETA DECAY RADIOISOTOPES</subject><subject>BETA-PLUS DECAY RADIOISOTOPES</subject><subject>Biological and medical sciences</subject><subject>BODY</subject><subject>Carcinoma, Non-Small-Cell Lung - diagnostic imaging</subject><subject>Carcinoma, Non-Small-Cell Lung - metabolism</subject><subject>Carcinoma, Non-Small-Cell Lung - radiotherapy</subject><subject>CAT SCANNING</subject><subject>Chemoradiotherapy</subject><subject>COMPUTERIZED TOMOGRAPHY</subject><subject>DIAGNOSTIC TECHNIQUES</subject><subject>DISEASES</subject><subject>DOSES</subject><subject>DRUGS</subject><subject>Dyspnea</subject><subject>Dyspnea - etiology</subject><subject>EMISSION COMPUTED TOMOGRAPHY</subject><subject>Female</subject><subject>FLUORINE 18</subject><subject>FLUORINE ISOTOPES</subject><subject>FLUORODEOXYGLUCOSE</subject><subject>Fluorodeoxyglucose (FDG)</subject><subject>Fluorodeoxyglucose F18 - pharmacokinetics</subject><subject>HAZARDS</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>HOURS LIVING RADIOISOTOPES</subject><subject>Humans</subject><subject>HYPOTHESIS</subject><subject>INFLAMMATION</subject><subject>ISOMERIC TRANSITION ISOTOPES</subject><subject>ISOTOPES</subject><subject>LIGHT NUCLEI</subject><subject>Logistic Models</subject><subject>Lung</subject><subject>Lung - diagnostic imaging</subject><subject>Lung - metabolism</subject><subject>Lung - radiation effects</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - diagnostic imaging</subject><subject>Lung Neoplasms - metabolism</subject><subject>Lung Neoplasms - radiotherapy</subject><subject>LUNGS</subject><subject>Male</subject><subject>Medical sciences</subject><subject>MEDICINE</subject><subject>Middle Aged</subject><subject>Multimodal Imaging - methods</subject><subject>NANOSECONDS LIVING RADIOISOTOPES</subject><subject>NEOPLASMS</subject><subject>NUCLEAR MEDICINE</subject><subject>NUCLEI</subject><subject>ODD-ODD NUCLEI</subject><subject>Odds Ratio</subject><subject>ORGANS</subject><subject>PATHOLOGICAL CHANGES</subject><subject>Pneumology</subject><subject>PNEUMONITIS</subject><subject>POSITRON COMPUTED TOMOGRAPHY</subject><subject>Positron emission tomography (PET)</subject><subject>Positron-Emission Tomography</subject><subject>Radiation</subject><subject>RADIATION DOSES</subject><subject>RADIATION EFFECTS</subject><subject>Radiation Pneumonitis - diagnostic imaging</subject><subject>Radiation Pneumonitis - metabolism</subject><subject>Radiation-induced lung toxicity (RILT)</subject><subject>RADIOISOTOPES</subject><subject>RADIOLOGY</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>Radiopharmaceuticals - pharmacokinetics</subject><subject>RADIOTHERAPY</subject><subject>Respiration</subject><subject>RESPIRATORY SYSTEM</subject><subject>Respiratory system : syndromes and miscellaneous diseases</subject><subject>Retrospective Studies</subject><subject>SYMPTOMS</subject><subject>THERAPY</subject><subject>TOMOGRAPHY</subject><subject>Tomography, X-Ray Computed</subject><subject>TOXICITY</subject><subject>Tumors</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>0360-3016</issn><issn>1879-355X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFktuKFDEQhhtR3HH1DUQaRPCmx6SP6RthHVwdGA84uyCIhHRS2U1vJmmTtGy_lM9o2h4VvPEqUPmq6q_6K0keY7TGCNcv-rXqne2GdY5iCNXrGLyTrDBp2qyoqs93kxUqapQVMX6SPPC-Rwhh3JT3k5McEVLinKySH18wSc-_Sj1aZwXY2-lKj9x6SC-HwG4g_chCAGd8qky6G81V-gqkdZB-YkLZcA2ODVO6FWCCklN65oD59N0M7EfPYQiq05AG-4tnQVmTbY0YOYil2oW9VVyFaS7_Pn7uD0zrbANaL_8bZji4WYWKLfzD5J5k2sOj43uaXJ6_vti8zXYf3mw3Z7uMV1URsq4UuCNcgGwrJsuOc8A1byAXkneYFKio6orXOC84kmUhSFU2LQEiS2BMSl6cJk-XutYHRX1UCPyaW2OAB5rjqkVl3kbq-UINzn4bwQd6UHForZkBO3qK86ohcdOkiWi5oNxZ7x1IOjh1YG6iGNHZT9rTxU86-0lRTWMwpj05dhi7A4g_Sb8NjMCzI8A8Z1q6uC_l_3Jlg5qmnaW-XDiIW_uuwM1DQdytUG6eSVj1PyX_FuBaGRV73sAEvrejM9ERiqnPKaL7-fbm08Px6kgdXfkJtc3X_w</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Petit, Steven F., M.Sc</creator><creator>van Elmpt, Wouter J.C., Ph.D</creator><creator>Oberije, Cary J.G., M.Sc</creator><creator>Vegt, Erik, M.D</creator><creator>Dingemans, Anne-Marie C., Ph.D</creator><creator>Lambin, Philippe, M.D., Ph.D</creator><creator>Dekker, André L.A.J., Ph.D</creator><creator>De Ruysscher, Dirk, M.D., Ph.D</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>OTOTI</scope></search><sort><creationdate>20111101</creationdate><title>[18 F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients</title><author>Petit, Steven F., M.Sc ; van Elmpt, Wouter J.C., Ph.D ; Oberije, Cary J.G., M.Sc ; Vegt, Erik, M.D ; Dingemans, Anne-Marie C., Ph.D ; Lambin, Philippe, M.D., Ph.D ; Dekker, André L.A.J., Ph.D ; De Ruysscher, Dirk, M.D., Ph.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c553t-b4d1b8cdef95af4bcce16c7e2dfcb18303565c6123c0f43d854798e8f4eaaffc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Age</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>ANTIMETABOLITES</topic><topic>BETA DECAY RADIOISOTOPES</topic><topic>BETA-PLUS DECAY RADIOISOTOPES</topic><topic>Biological and medical sciences</topic><topic>BODY</topic><topic>Carcinoma, Non-Small-Cell Lung - diagnostic imaging</topic><topic>Carcinoma, Non-Small-Cell Lung - metabolism</topic><topic>Carcinoma, Non-Small-Cell Lung - radiotherapy</topic><topic>CAT SCANNING</topic><topic>Chemoradiotherapy</topic><topic>COMPUTERIZED TOMOGRAPHY</topic><topic>DIAGNOSTIC TECHNIQUES</topic><topic>DISEASES</topic><topic>DOSES</topic><topic>DRUGS</topic><topic>Dyspnea</topic><topic>Dyspnea - etiology</topic><topic>EMISSION COMPUTED TOMOGRAPHY</topic><topic>Female</topic><topic>FLUORINE 18</topic><topic>FLUORINE ISOTOPES</topic><topic>FLUORODEOXYGLUCOSE</topic><topic>Fluorodeoxyglucose (FDG)</topic><topic>Fluorodeoxyglucose F18 - pharmacokinetics</topic><topic>HAZARDS</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>HOURS LIVING RADIOISOTOPES</topic><topic>Humans</topic><topic>HYPOTHESIS</topic><topic>INFLAMMATION</topic><topic>ISOMERIC TRANSITION ISOTOPES</topic><topic>ISOTOPES</topic><topic>LIGHT NUCLEI</topic><topic>Logistic Models</topic><topic>Lung</topic><topic>Lung - diagnostic imaging</topic><topic>Lung - metabolism</topic><topic>Lung - radiation effects</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - diagnostic imaging</topic><topic>Lung Neoplasms - metabolism</topic><topic>Lung Neoplasms - radiotherapy</topic><topic>LUNGS</topic><topic>Male</topic><topic>Medical sciences</topic><topic>MEDICINE</topic><topic>Middle Aged</topic><topic>Multimodal Imaging - methods</topic><topic>NANOSECONDS LIVING RADIOISOTOPES</topic><topic>NEOPLASMS</topic><topic>NUCLEAR MEDICINE</topic><topic>NUCLEI</topic><topic>ODD-ODD NUCLEI</topic><topic>Odds Ratio</topic><topic>ORGANS</topic><topic>PATHOLOGICAL CHANGES</topic><topic>Pneumology</topic><topic>PNEUMONITIS</topic><topic>POSITRON COMPUTED TOMOGRAPHY</topic><topic>Positron emission tomography (PET)</topic><topic>Positron-Emission Tomography</topic><topic>Radiation</topic><topic>RADIATION DOSES</topic><topic>RADIATION EFFECTS</topic><topic>Radiation Pneumonitis - diagnostic imaging</topic><topic>Radiation Pneumonitis - metabolism</topic><topic>Radiation-induced lung toxicity (RILT)</topic><topic>RADIOISOTOPES</topic><topic>RADIOLOGY</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>Radiopharmaceuticals - pharmacokinetics</topic><topic>RADIOTHERAPY</topic><topic>Respiration</topic><topic>RESPIRATORY SYSTEM</topic><topic>Respiratory system : syndromes and miscellaneous diseases</topic><topic>Retrospective Studies</topic><topic>SYMPTOMS</topic><topic>THERAPY</topic><topic>TOMOGRAPHY</topic><topic>Tomography, X-Ray Computed</topic><topic>TOXICITY</topic><topic>Tumors</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Petit, Steven F., M.Sc</creatorcontrib><creatorcontrib>van Elmpt, Wouter J.C., Ph.D</creatorcontrib><creatorcontrib>Oberije, Cary J.G., M.Sc</creatorcontrib><creatorcontrib>Vegt, Erik, M.D</creatorcontrib><creatorcontrib>Dingemans, Anne-Marie C., Ph.D</creatorcontrib><creatorcontrib>Lambin, Philippe, M.D., Ph.D</creatorcontrib><creatorcontrib>Dekker, André L.A.J., Ph.D</creatorcontrib><creatorcontrib>De Ruysscher, Dirk, M.D., Ph.D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>OSTI.GOV</collection><jtitle>International journal of radiation oncology, biology, physics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Petit, Steven F., M.Sc</au><au>van Elmpt, Wouter J.C., Ph.D</au><au>Oberije, Cary J.G., M.Sc</au><au>Vegt, Erik, M.D</au><au>Dingemans, Anne-Marie C., Ph.D</au><au>Lambin, Philippe, M.D., Ph.D</au><au>Dekker, André L.A.J., Ph.D</au><au>De Ruysscher, Dirk, M.D., Ph.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>[18 F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients</atitle><jtitle>International journal of radiation oncology, biology, physics</jtitle><addtitle>Int J Radiat Oncol Biol Phys</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>81</volume><issue>3</issue><spage>698</spage><epage>705</epage><pages>698-705</pages><issn>0360-3016</issn><eissn>1879-355X</eissn><coden>IOBPD3</coden><abstract>Purpose Our hypothesis was that pretreatment inflammation in the lung makes pulmonary tissue more susceptible to radiation damage. The relationship between pretreatment [18 F]fluorodeoxyglucose ([18 F]FDG) uptake in the lungs (as a surrogate for inflammation) and the delivered radiation dose and radiation-induced lung toxicity (RILT) was investigated. Methods and Materials We retrospectively studied a prospectively obtained cohort of 101 non-small-cell lung cancer patients treated with (chemo)radiation therapy (RT). [18 F]FDG-positron emission tomography-computed tomography (PET-CT) scans used for treatment planning were studied. Different parameters were used to describe [18 F]FDG uptake patterns in the lungs, excluding clinical target volumes, and the interaction with radiation dose. An increase in the dyspnea grade of 1 (Common Terminology Criteria for Adverse Events version 3.0) or more points compared to the pre-RT score was used as an endpoint for analysis of RILT. The effect of [18 F]FDG and CT-based variables, dose, and other patient or treatment characteristics that effected RILT was studied using logistic regression. Results Increased lung density and pretreatment [18 F]FDG uptake were related to RILT after RT with univariable logistic regression. The 95th percentile of the [18 F]FDG uptake in the lungs remained significant in multivariable logistic regression ( p = 0.016; odds ratio [OR] = 4.3), together with age ( p = 0.029; OR = 1.06), and a pre-RT dyspnea score of ≥1 ( p = 0.005; OR = 0.20). Significant interaction effects were demonstrated among the 80th, 90th, and 95th percentiles and the relative lung volume receiving more than 2 and 5 Gy. Conclusions The risk of RILT increased with the 95th percentile of the [18 F]FDG uptake in the lungs, excluding clinical tumor volume (OR = 4.3). The effect became more pronounced as the fraction of the 5%, 10%, and 20% highest standardized uptake value voxels that received more than 2 Gy to 5 Gy increased. Therefore, the risk of RILT may be decreased by applying sophisticated radiotherapy techniques to avoid areas in the lung with high [18 F]FDG uptake.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>20884128</pmid><doi>10.1016/j.ijrobp.2010.06.016</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0360-3016 |
ispartof | International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.698-705 |
issn | 0360-3016 1879-355X |
language | eng |
recordid | cdi_osti_scitechconnect_21590429 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adult Age Age Factors Aged Aged, 80 and over ANTIMETABOLITES BETA DECAY RADIOISOTOPES BETA-PLUS DECAY RADIOISOTOPES Biological and medical sciences BODY Carcinoma, Non-Small-Cell Lung - diagnostic imaging Carcinoma, Non-Small-Cell Lung - metabolism Carcinoma, Non-Small-Cell Lung - radiotherapy CAT SCANNING Chemoradiotherapy COMPUTERIZED TOMOGRAPHY DIAGNOSTIC TECHNIQUES DISEASES DOSES DRUGS Dyspnea Dyspnea - etiology EMISSION COMPUTED TOMOGRAPHY Female FLUORINE 18 FLUORINE ISOTOPES FLUORODEOXYGLUCOSE Fluorodeoxyglucose (FDG) Fluorodeoxyglucose F18 - pharmacokinetics HAZARDS Hematology, Oncology and Palliative Medicine HOURS LIVING RADIOISOTOPES Humans HYPOTHESIS INFLAMMATION ISOMERIC TRANSITION ISOTOPES ISOTOPES LIGHT NUCLEI Logistic Models Lung Lung - diagnostic imaging Lung - metabolism Lung - radiation effects Lung cancer Lung Neoplasms - diagnostic imaging Lung Neoplasms - metabolism Lung Neoplasms - radiotherapy LUNGS Male Medical sciences MEDICINE Middle Aged Multimodal Imaging - methods NANOSECONDS LIVING RADIOISOTOPES NEOPLASMS NUCLEAR MEDICINE NUCLEI ODD-ODD NUCLEI Odds Ratio ORGANS PATHOLOGICAL CHANGES Pneumology PNEUMONITIS POSITRON COMPUTED TOMOGRAPHY Positron emission tomography (PET) Positron-Emission Tomography Radiation RADIATION DOSES RADIATION EFFECTS Radiation Pneumonitis - diagnostic imaging Radiation Pneumonitis - metabolism Radiation-induced lung toxicity (RILT) RADIOISOTOPES RADIOLOGY RADIOLOGY AND NUCLEAR MEDICINE Radiopharmaceuticals - pharmacokinetics RADIOTHERAPY Respiration RESPIRATORY SYSTEM Respiratory system : syndromes and miscellaneous diseases Retrospective Studies SYMPTOMS THERAPY TOMOGRAPHY Tomography, X-Ray Computed TOXICITY Tumors Tumors of the respiratory system and mediastinum |
title | [18 F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T03%3A37%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%5B18%20F%5Dfluorodeoxyglucose%20Uptake%20Patterns%20in%20Lung%20Before%20Radiotherapy%20Identify%20Areas%20More%20Susceptible%20to%20Radiation-Induced%20Lung%20Toxicity%20in%20Non-Small-Cell%20Lung%20Cancer%20Patients&rft.jtitle=International%20journal%20of%20radiation%20oncology,%20biology,%20physics&rft.au=Petit,%20Steven%20F.,%20M.Sc&rft.date=2011-11-01&rft.volume=81&rft.issue=3&rft.spage=698&rft.epage=705&rft.pages=698-705&rft.issn=0360-3016&rft.eissn=1879-355X&rft.coden=IOBPD3&rft_id=info:doi/10.1016/j.ijrobp.2010.06.016&rft_dat=%3Cproquest_osti_%3E1257888487%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1257888487&rft_id=info:pmid/20884128&rft_els_id=S0360301610008655&rfr_iscdi=true |